Senate Passes Broad Opioid Package to Address National Crisis

Senate passes opioid package

The Council on Recovery applauds the U.S. Senate’s passage of the final version of a sweeping opioids package Wednesday. Passed with rare bipartisan support by a vote of 98-1, the bill will be sent it to the White House for expected signature.

The bill represents Congressional response to the opioid epidemic, a growing public health crisis that resulted in 72,000 drug-overdose deaths last year. The House of Representatives passed the bill last week. It combines dozens of smaller proposals, from both sides of the aisle, that affect every federal agency. The bill is aimed at addressing different aspects of the opioid crisis, including prevention, treatment and recovery.

Major Provisions

Among major provisions, the legislation creates a grant program for comprehensive recovery centers that include housing and job training, as well as mental and physical health care. It also increases access to medication-assisted treatment to help people with substance abuse disorders safely detox from the opioids.

Another portion of the bill changes a prohibition that limited Medicaid from covering patients with substance abuse disorders who were receiving treatment in a mental health facility with more than 16 beds. The bill lifts that rule to allow for 30 days of residential treatment coverage.

The bill also gives Medicare beneficiaries more information on alternative pain treatments, and expands treatment options for enrollees who are addicted to opioids.

Funding in the Bill

Congress has appropriated $8.5 billion this year for opioid-related programs, but has not guaranteed funding for subsequent years. Some members of Congress have proposed committing at least $100 billion over ten years to fight the opioid epidemic.

The Council on Recovery

The Council on Recovery is in the vanguard of local efforts to stem the opioid epidemic with a broad array of prevention, education, treatment, and recovery programs. The Council also recently hosted the 2018 Houston Opioid Summit. For more information about our services, contact us today.

Yale Study: Genes May Explain Why Alcohol Detox is Particularly Hard for Some People

Detox
Yale Study Explains Why Detox Symptoms are Worse for Some, Not Others

New findings published in journal Alcoholism: Clinical and Experimental Research

Some heavy drinkers suffer intense withdrawal symptoms when they try to stop drinking — some, less so.  A new Yale-led international study of individuals with alcohol dependence has identified gene variants that may help explain why “detox” from alcohol is particularly difficult for some people. The researchers report their findings September 25 in the journal Alcoholism: Clinical and Experimental Research, the official journal of the Research Society on Alcoholism.

Alcohol takes more lives in the United States every year than opioids, but there are few effective treatments to help people who have an alcohol use disorder,” said Andrew H. Smith, lead author of the study and a research affiliate in the laboratory of senior author Joel Gelernter, Foundations Fund Professor of Psychiatry and Professor of Genetics and of Neuroscience. “For people who experience intense withdrawal symptoms, that’s one more barrier they have to face while trying to reduce unhealthy alcohol use.”

Those physical symptoms of alcohol withdrawal are much worse than any hangover. Sudden cessation of alcohol consumption can lead to shakes, nausea, headaches, anxiety, fluctuations in blood pressure, and in the most serious cases, seizures.

The American team and collaborators in Denmark linked variants in the SORCS2 gene to the severity of alcohol withdrawal in people who have European ancestry, about one in ten of whom carry the variants. No such connection was found in African Americans. Intriguingly, the SORCS2 gene is important for activation of brain areas which respond to changes in the environment. The gene variants identified in the study may impinge on the ability of heavy drinkers to adapt to the sudden absence of alcohol, researchers speculate.

Better understanding of the many genes likely to be involved in withdrawal symptoms could ultimately lead to new medications that moderate these symptoms, which could help with the discontinuation of habitual alcohol use,” Gelernter said.

The research was primarily funded by grants from the National Institutes of Health.


The Council on Recovery does not provide medical detox services, but does refer out to detox facilities in the Houston area. The Council provides outpatient services for people battling alcoholism, including Healing Choices, our intensive outpatient treatment program (IOP). Call 713.914.0556 for more information.

How Drugs Alter Brain Development and Affect Teens

Adolescent Brain 3Changes in Brain Development and Function From Drug Abuse

Most kids grow dramatically during the adolescent and teen years. Their young brains, particularly the prefrontal cortex that is used to make decisions, are growing and developing, until their mid-20’s.

Long-term drug use causes brain changes that can set people up for addiction and other problems. Once a young person is addicted, his or her brain changes so that drugs are now the top priority. He or she will compulsively seek and use drugs even though doing so brings devastating consequences to his or her life, and for those who care about him.

(See moreStudy: Regularly Using Marijuana as a Teen Slows Brain Development)

Alcohol can interfere with developmental processes occurring in the brain. For weeks or months after a teen stops drinking heavily, parts of the brain still struggle to work correctly. Drinking at a young age is also associated with the development of alcohol dependence later in life.

What is Addiction?

No one plans to become addicted to a drug. Instead, it begins with a single use, which can lead to abuse, which can lead to addiction.

The National Institute of Drug Abuse (NIDA) defines addiction as:

A chronic, relapsing brain disease that is characterized by compulsive drug seeking and use, despite harmful consequences. Addiction is a brain disease because drugs change the brain’s structure and how it works. These brain changes can be long lasting, and lead to harmful behaviors seen in people who abuse drugs.

The good news is that addiction is treatable. The treatment approach to substance abuse depends on several factors, including a child’s temperament and willingness to change. It may take several attempts at treatment before a child remains drug-free. For those teens who are treated for addiction, there is hope for a life of recovery.

The Council on Recovery’s Center for Recovering Families has a broad spectrum of outpatient services for adolescents, including individual therapy, group therapy, high-risk behavior classes, and other education and treatment programs. For information, call 713-914-0556.

(Source: Get Smart About Drugs, a DEA Resource for Parents, Educators, & Caregivers)

The Lifelong Quest For Sobriety…The Ultimate Hero’s Journey—Part 39

Guest Blogger and long-time Council friend, Bob W. presents Part 39 of a series dealing with Alcoholism and Addiction from a Mystical, Mythological Perspective, reflecting Bob’s scholarly work as a Ph.D. in mythological studies.

In Greek mythology, the heiros gamos is a holy ritual, a sacred marriage of a god and goddess, or of an archetypal masculine and feminine, that results in a perfect union of certain key elements of the human experience. It appears in many other systems – mythological, spiritual and psychological – in the same context, a glorified union of the key elements of both genders of humanity.

It occurs to me, though, that we might see just such a phenomenon in the evolution of our own individual selves in the recovery process from addictions.

In broad psychoanalytic terms, the two key elements of the human psyche could be seen as the ego, the conscious element of ourselves – how and what we see of ourselves – and the self – that part of us that is who we truly are, at the core of our beings. The ego is what is crafted from the earliest times, formed by how we fit into the world in which we are raised.  In time it may be cloaked by a certain persona that we want (or are taught) the world to see. This may or may not be akin to our authentic selves. The self, on the other hand, is who and what we are at the core, from our earliest consciousness, regardless of how we were raised, or what happened to us over our lives.  It is the self that will ultimately define us.

For those of us inflicted with the diseases of alcoholism or addiction, our egos became the ruling elements of our psyche. Maybe we strove to achieve, working hard against all odds, and built a view of ourselves that was at best majestic, at worst massively grandiose. This view fed our alcoholism, both to elevate its absurdity as well as to medicate the hidden anxiety that it created.  When it got to be too painful to perpetuate, we crashed, monumentally. We hit that point at which there had to be another way to live in the world or the grim reaper of death would become our only companion in a descent to oblivion.

The journey to recovery thus begun also became a slow and developing process to rewire our own brains.  For this alcoholic, it signaled a journey of discovery to find myself, the core of who and what I am. The last stages of this journey, for me, is becoming a heiros gamos, a marriage of my ego and my self. The ego is still important to me, to us; it is the warrior part of us, that part infused with a healthy narcissism, enabling me/us to face the world without a debilitating fear that needs medication.  But the self, that core of who and what we are, must come forward, must rise up in stature to form a true union of equals with our ego.

The union thus created by my own heiros gamos, this spectacular sensation of finally feeling, fully and completely, who and what I am and what I can be, is a gift of grace of unimaginable magnitude.  More on this in a later note….

Cornyn, Feinstein Substance Abuse Prevention Bill Passes in Opioids Package

US Senate 1
U.S. Senate Passes of The Opioid Crisis Response Act of 2018

The Council on Recovery applauds the efforts of the United States Senate in passing the Opioid Crisis Response Act of 2018 by a vote of 99-1. The bill included the Substance Abuse Prevention Act, sponsored by Senators John Cornyn and Dianne Feinstein. The following press release was issued shortly after the bill passed:

U.S. Senators John Cornyn (R-TX) and Dianne Feinstein (D-CA) released the following statements after their Substance Abuse Prevention Act, a bipartisan bill to reauthorize drug abuse programs, passed as a part of The Opioid Crisis Response Act of 2018.

“Our nation continues to suffer from a drug crisis, and this critical legislation will combat the supply of opioids and help individuals and families suffering from substance abuse,” said Sen. Cornyn. “By including the Substance Abuse Prevention Act in this bill, we will be able to strengthen the ability of law enforcement and healthcare agencies to reduce addiction and support those in recovery.”

“Drug addiction and overdoses have reached crisis levels in our country,” Sen. Feinstein said. “In order to address this issue we must strengthen the agencies and programs that are focused on stopping drug use before it starts, dismantle drug trafficking organizations and expand access to treatment. This bill embraces that strategy by reauthorizing the Office of National Drug Control Policy and other successful initiatives like the Drug-Free Communities and High Intensity Drug Trafficking Areas programs. The bill also establishes new programs to provide law enforcement with tools, training and equipment to detect and prevent fentanyl-related overdoses and to ensure families and children have more access to substance abuse treatment.”

Background:

The Substance Abuse Prevention Act was originally introduced by Senators Cornyn and Feinstein to reauthorize drug abuse programs, and to provide assistance to various agencies so they can better combat opioid addiction and support those recovering from substance abuse.

  • Office of National Drug Control Policy: Reauthorizes the Office of National Drug Control Policy (ONDCP) at the White House, which oversees Executive Branch efforts on narcotics control and ensures efforts complement and strengthen state and local anti-drug activates.
  • Drug Abuse Prevention Programs: Reauthorizes several important programs under the ONDCP including the Drug-Free Communities Program and the High-Intensity Drug Trafficking Area Program and allows the ONDCP Director to participate in and expand opioid and heroin awareness campaigns which were authorized under the Comprehensive Addiction and Recovery Act (CARA).
  • Drug Courts: Reauthorizes Department of Justice funding for drug courts, which provide targeted interventions for individuals with drug addiction and substance abuse disorders and allows non-profit organizations to provide important training and technical assistance to drug courts.
  • Supporting Families with Substance Abuse Challenges: Provides resources to the Department of Health and Humans Services (HHS) for screening, treatment, supportive housing, and interventions in order to help support families as they battle substance abuse challenges.
  •  Better Substance Abuse Treatment: Directs the Government Accountability Office (GAO) to conduct a study on reimbursements for substance use disorder services and make recommendations in order to bring parity to and improve reimbursements.
  • Educating Prescribers: Requires Attorney General and HHS Secretary to complete a plan for educating and training medical practitioners in best practices for prescribing controlled substances.
  • Supporting Education and Awareness: Allows the Attorney General to make grants available to entities that focus on substance use disorders and specialize in family and patient services.
  • Sobriety Treatment and Recovery Teams: Authorizes the Director of ONDCP in coordination with SAMHSA to provide grants to establish Sobriety Treatment and Recovery Teams (START) to determine the effectiveness of pairing social workers and mentors with families that are struggling with substance use disorder and child abuse or neglect.

The following groups supported the Substance Abuse Prevention Act: the Community Anti-Drug Coalitions of America (CADCA), the Addiction Policy Forum, the National Association for Children of Addiction (NACoA), the Moyer Foundation, the National Council for Behavioral Health, the National District Attorneys Association, the Fraternal Order of Police, the National HIDTA Directors Association, the Partnership for Drug-Free Kids, the National Criminal Justice Association, the National Association of Police Organizations, and the National Association of Drug Court Professionals.

CNN Reports Nearly 30% of All Opioid Prescriptions Lack Medical Explanation

CNN Report Opioid Rx Lack Medical
Nearly 30% of All Opioid Prescriptions Lack Medical Explanation [Click to watch CNN report]
This CNN story reported findings of a recent study by the Annals of Internal Medicine that indicated nearly 30% of all opioid prescriptions lack medical explanation:

(CNN) How large a role do doctors play in the opioid crisis? Nearly 30% of all opioids prescribed in US clinics or doctors’ offices lack a documented reason — such as severe back pain — to justify a script for these addictive drugs, new research finds.

In total, opioids were prescribed in almost 809 million outpatient visits over a 10-year period, with 66.4% of these prescriptions intended to treat non-cancer pain and 5.1% for cancer-related pain, according to a study published Monday in the journal Annals of Internal Medicine.

However, for the remaining 28.5% of prescriptions — about three out of every 10 patients — there was no record of either pain symptoms or a pain-related condition, the Harvard Medical School and RAND Corp. researchers say.

‘Inappropriate prescribing’

“For these visits, it is unclear why a physician chose to prescribe an opioid or whether opioid therapy is justified,” said Dr. Tisamarie B. Sherry, lead author of the study and an associate physician policy researcher at RAND. “The reasons for this could be truly inappropriate prescribing of opioids or merely lax documentation.”

Sherry and her colleagues, who analyzed data from the National Ambulatory Medical Care Survey for 2006 through 2015, say the most common diagnoses at doctor visits that lacked medical justification were high blood pressure, high cholesterol, opioid dependence and “other follow-up examination.”

Opioid dependence, which accounted for only 2.2% of these diagnoses, cannot explain why a doctor failed to give an adequate reason for prescribing addictive painkillers.

“If a doctor does not document a medical reason for prescribing an opioid, it could mean that the prescription is not clinically appropriate,” Sherry said. “But it could also mean that the doctor simply missed recording the medical justification for an opioid, perhaps due to time constraints, clinic workflows or complicated documentation systems.”

We cannot assume that poor record-keeping “indicates a nefarious purpose on the part of the doctor,” she added.

Social media’s contribution

Tim K. Mackey, an associate professor at the University of California, San Diego School of Medicine and director of the Global Health Policy Institute, described the new study as “an important analysis,” with the findings highlighting “gaps in our understanding of why clinicians prescribed opioids.”

Mackey, who did not participate in the research, believes that the study could lead to stricter prescribing guidelines, which in turn could give rise to “unforeseen consequences.” For example, if new guidelines and initiatives make it harder for people to access opioids from hospitals and clinics, “this could shift demand to more accessible platforms, including the internet,” he wrote in an email.

“The public health danger of sales of opioids online has been well recognized by the US government, with a US General Accounting Office report from as early as 2004 warning about pain medications available online without a prescription,” he said.

Mackey’s own research highlights how online pharmacies use social media to sell controlled substances while drug dealers use Twitter to sell opioids by including their phone or email information.
Someone may start by getting medication for a legitimate “pain” diagnosis, but once they become addicted, their health provider may no longer be willing to write scripts, Mackey said.

“After exhausting friends, relatives and other personal contacts, many may go to illicit channels, including street buys no longer confined to the ‘street’ but digitized on social media,” he said. Some turn to internet pharmacies despite concerns about fraud and identify theft.

“Either way, this dangerous progression of different access points that continues to enable the opioid epidemic is not well understood,” Mackey said.

With more data needed to make sense of this public health crisis, technology companies, regulators, law enforcement and researchers need to come together to share ideas, innovations and research, he said.
“Unfortunately, some of this needed collaboration may be elusive,” he said. He explained that researchers who use machine-learning and Twitter’s public application programming interface to detect illicit online activity are prevented from sharing their findings with law enforcement due to Twitter’s terms of use.

“This leaves regulators like the US Food and Drug Administration and the US Department of Justice in the dark about how they can cut off this dangerous channel of access that may continue to fuel the opioid crisis even after we make strides in other areas, such as physician prescribing,” Mackey said.

Sherry said another key finding of her study was that “physicians were especially lax at documenting their medical reasons for continuing chronic opioid prescriptions” despite government guidelines from 2016 recommending “periodic formal re-evaluation” in cases of long-term opioid treatment.

“It is now more important than ever for physicians to transparently and accurately document their justification for using an opioid so that we can identify and rectify problematic prescribing behavior,” Sherry said. “Our findings indicate that we still have a long way to go to reach this goal.”